Careview Communications, Inc.

Item 1.01 Entry into a Material Definitive Agreement. Fifteenth Amendment to Credit Agreement; Extended Maturity Date As previously reported, CareView Communications, Inc. (and together with its subsidiaries, as applicable, the “Company”), CareView Communications, Inc., a Texas corporation and a wholly owned subsidiary of the Company (the “Borrower”), and PDL Investment Holdings, LLC (as assignee of PDL BioPharma, Inc.), in its capacity as administrative agent and lender (the “Lender”) entered into that certain Credit Agreement as of June 26, 2015 (the “Credit Agreement”). The Company, Borrower and Lender are sometimes referred to herein collectively as the “Parties.” Any capitalized terms not defined herein shall have the definitions as ascribed in the Credit Agreement. The Parties subsequently entered into a Modification Agreement to the Credit Agreement as of February 2, 2018 (“Modification Agreement”). The Parties thereafter entered into amendments to the Modification Agreement (“Amendment to MA”) as follows: First Amendment to MA as of May 31, 2018, Second Amendment to MA as of June 14, 2018, Third Amendment to MA as of June 28, 2018, Fourth Amendment to MA as of August 31, 2018, Fifth Amendment to MA as of September 28, 2018, Sixth Amendment to MA as of November 12, 2018, Seventh Amendment to MA as of November 19, 2018, Eighth Amendment to MA as of December 3, 2018, Ninth Amendment to MA as of December 17, 2018, Tenth Amendment to MA as of January 31, 2019, Eleventh Amendment to MA as of February 28, 2019, Twelfth Amendment to MA as of March 29, 2019, Thirteenth Amendment to MA as of April 29, 2019, Fourteenth Amendment to MA as of May 15, 2019, Fifteenth Amendment to MA as of September 30, 2019, Sixteenth Amendment to MA as of November 29, 2019, Seventeenth Amendment to MA as of December 31, 2019, Eighteenth Amendment to MA as of January 17, 2020, Nineteenth Amendment to MA as of January 28, 2020, Twentieth Amendment to MA as of April 17, 2020, Twenty-first Amendment to MA as of September 30, 2020, Twenty-second Amendment to MA as of November 30, 2020, Twenty-third Amendment to MA as of January 31, 2021, Twenty-fourth Amendment to MA as of May 25, 2021, Twenty-fifth Amendment to MA as of November 29, 2021, Twenty-sixth Amendment to MA as of June 23, 2022, Twenty-seventh Amendment to MA as of December 30, 2022, Twenty-eighth Amendment to MA as of February 28, 2023, Twenty-Ninth Amendment to MA as of March 31, 2023, and Thirtieth Amendment to MA as of April 29, 2023. The Parties also entered into amendments to the Credit Agreement (“Amendment to CA”) as follows: First Amendment to CA as of October 7, 2015, Second Amendment to CA as of February 23, 2018, Third Amendment to CA as of July 13, 2018, Fourth Amendment to CA as of April 9, 2019, Fifth Amendment to CA as of May 15, 2019, Sixth Amendment to CA as of February 6, 2020, Seventh Amendment to CA as of May 31, 2023, Eighth Amendment as of October 24, 2023, Ninth Amendment to CA as of December 11, 2024, Tenth Amendment to CA as of March 21, 2025, Eleventh Amendment to CA as of June 30, 2025, Twelfth Amendment to CA as of September 30, 2025, Thirteenth Amendment to CA as of December 31, 2025, and Fourteenth Amendment to CA as of March 30, 2026. As of June 30, 2026, the Company, the Borrower, the Lender, Steven G. Johnson, President and Chief Executive Officer of the Company, and Dr. James R. Higgins, a director of the Company, entered into a Fifteenth Amendment to CA (the “Fifteenth Amendment to Credit Agreement”), pursuant to which the parties agreed to amend the Credit Agreement to (i) provide that the Maturity Date shall be extended to September 30, 2026. The foregoing descriptions of the Fifteenth Amendment to Credit Agreement are qualified, in their entirety, by reference to such amendment, a copy of which is attached as Exhibit 10.47 to this Current Report on Form 8-K and is incorporated by reference in response to this Item 1.01.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information set forth in Item 1.01 of this Current Report on Form 8-K that relates to the creation of direct financial obligations of the Company is incorporated by reference into this Item 2.03.